Molecular Designs Earns Its First FDA 510(k) Clearance with SimplicityDx™ Panel FluA/FluB/RSV

Markets PR Newswire By PR Newswire 13 Nov 2026 17:03 1 min read
Molecular Designs Earns Its First FDA 510(k) Clearance with SimplicityDx™ Panel FluA/FluB/RSV

Multiplex real-time RT-PCR test detects and differentiates influenza A, influenza B and RSV in anterior nasal swab specimens, with a breakaway format built around lab workflows Molecular Designs' first FDA-cleared assay, developed by a physician-founded team Breakaway format designed so...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.